Recently, DHX38/PRP16 has been implicated in the proliferative potential of the HCT116 colorectal carcinoma cell line, where cells harboring an active KRAS mutant become responsive to DHX38/PRP16 knockdown [26]. Here, KRAS is linked to colorectal carcinoma.